Verus Capital Partners LLC lowered its stake in Lam Research Corporation (NASDAQ:LRCX – Free Report) by 42.2% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 3,018 shares of the semiconductor company’s stock after selling 2,207 shares during the period. Verus Capital Partners LLC’s holdings in Lam Research were worth $645,000 at the end of the most recent reporting period.
Several other large investors have also modified their holdings of the stock. GSG Advisors LLC raised its position in Lam Research by 3.1% during the 1st quarter. GSG Advisors LLC now owns 1,387 shares of the semiconductor company’s stock worth $296,000 after buying an additional 42 shares during the last quarter. Valued Wealth Advisors LLC boosted its holdings in shares of Lam Research by 7.9% in the first quarter. Valued Wealth Advisors LLC now owns 589 shares of the semiconductor company’s stock valued at $126,000 after acquiring an additional 43 shares in the last quarter. Greenup Street Wealth Management LLC boosted its holdings in shares of Lam Research by 1.8% in the first quarter. Greenup Street Wealth Management LLC now owns 2,433 shares of the semiconductor company’s stock valued at $520,000 after acquiring an additional 44 shares in the last quarter. Triumph Capital Management increased its stake in shares of Lam Research by 22.5% during the fourth quarter. Triumph Capital Management now owns 245 shares of the semiconductor company’s stock worth $42,000 after acquiring an additional 45 shares during the period. Finally, Traphagen Investment Advisors LLC increased its stake in shares of Lam Research by 2.4% during the fourth quarter. Traphagen Investment Advisors LLC now owns 1,963 shares of the semiconductor company’s stock worth $336,000 after acquiring an additional 46 shares during the period. Hedge funds and other institutional investors own 84.61% of the company’s stock.
Lam Research Trading Down 1.5%
Shares of Lam Research stock opened at $293.15 on Friday. The company has a 50-day moving average of $340.82 and a two-hundred day moving average of $276.47. Lam Research Corporation has a 12-month low of $90.93 and a 12-month high of $438.50. The company has a current ratio of 2.63, a quick ratio of 1.77 and a debt-to-equity ratio of 0.30. The stock has a market cap of $366.60 billion, a PE ratio of 50.89, a price-to-earnings-growth ratio of 1.74 and a beta of 1.80.
Lam Research Dividend Announcement
The company also recently declared a quarterly dividend, which was paid on Wednesday, July 8th. Stockholders of record on Wednesday, June 17th were given a $0.26 dividend. The ex-dividend date was Wednesday, June 17th. This represents a $1.04 dividend on an annualized basis and a dividend yield of 0.4%. Lam Research’s dividend payout ratio (DPR) is currently 18.06%.
Key Stories Impacting Lam Research
Here are the key news stories impacting Lam Research this week:
- Positive Sentiment: Strong fiscal fourth-quarter results and outlook: Lam reported record revenue of $6.72 billion, up approximately 30% year over year, and adjusted EPS of $1.82 versus the $1.69 consensus estimate. Management’s outlook for the next quarter—approximately $8.1 billion in revenue and $2.00–$2.30 in EPS—significantly exceeded expectations. NAND revenue more than doubled sequentially, while customer-support revenue reached another record. LRCX Q4 Earnings Beat on NAND and Customer Support Strength
- Positive Sentiment: AI and memory demand remain key catalysts: Analysts and investors see Lam benefiting from ongoing AI infrastructure spending, advanced chip production, NAND investment, packaging, and wafer-fabrication demand. Some commentary describes an “extraordinary runway” heading into 2027. This Chip Stock Could Be the Biggest Winner of the AI Memory Boom
- Positive Sentiment: China memory concerns may be overstated: Mizuho argued that fears of Chinese producer CXMT flooding the DRAM market and pressuring prices are overblown, easing a potential risk to semiconductor-equipment demand. Tech specialist explains why China memory fears are overblown
- Neutral Sentiment: Analyst views remain broadly constructive but targets are mixed: Needham reaffirmed a Buy rating and $390 target, while Morgan Stanley lowered its target from $404 to $367 and B. Riley reduced its target from $385 to $350, retaining Buy or Overweight ratings. The target cuts suggest expectations are being moderated after the rally, even though analysts still see potential upside. Needham Raises Lam Research EPS Estimates
- Negative Sentiment: Valuation and insider selling are overhangs: After rising roughly 3.9 times over five years and trading at a high earnings multiple, LRCX may be vulnerable to profit-taking. Reported insider activity shows sales rather than purchases over the past six months, reinforcing caution around current valuation. Has Lam Research Fallen Far Enough to Look Like a Bargain?
Insider Transactions at Lam Research
In other news, Director Abhijit Y. Talwalkar sold 18,282 shares of Lam Research stock in a transaction on Monday, July 13th. The stock was sold at an average price of $335.00, for a total transaction of $6,124,470.00. Following the completion of the transaction, the director owned 87,142 shares of the company’s stock, valued at $29,192,570. The trade was a 17.34% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Eric Brandt sold 54,500 shares of the business’s stock in a transaction dated Thursday, June 11th. The stock was sold at an average price of $350.80, for a total transaction of $19,118,600.00. Following the completion of the sale, the director owned 199,205 shares in the company, valued at $69,881,114. This represents a 21.48% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 80,441 shares of company stock valued at $27,614,296 in the last 90 days. 0.31% of the stock is currently owned by insiders.
Wall Street Analysts Forecast Growth
A number of equities research analysts recently commented on LRCX shares. Jefferies Financial Group set a $335.00 price objective on shares of Lam Research and gave the company a “buy” rating in a research report on Thursday. Seaport Research Partners initiated coverage on Lam Research in a research report on Monday, May 4th. They set a “buy” rating and a $300.00 target price on the stock. HSBC reissued a “hold” rating and set a $333.00 target price on shares of Lam Research in a research note on Monday, July 27th. The Goldman Sachs Group reissued a “buy” rating and issued a $290.00 price target on shares of Lam Research in a report on Thursday, April 23rd. Finally, TD Cowen restated a “buy” rating and issued a $400.00 price target (up from $340.00) on shares of Lam Research in a research note on Thursday, July 9th. One analyst has rated the stock with a Strong Buy rating, twenty-six have issued a Buy rating and five have given a Hold rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $358.47.
Get Our Latest Stock Analysis on Lam Research
Lam Research Profile
Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.
Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.
Featured Stories
- Five stocks we like better than Lam Research
- Popular’s Earnings Beat Shows Why This Bank Stock Keeps Climbing
- ABB’s Rotork Deal Could Put These Flow Control Stocks Back in Focus
- GE HealthCare Stock Climbs on Vital Diagnostics Demand
- Lost in Space: Why Aerospace Valuations Are Plummeting Right Now
Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCX – Free Report).
Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.
